Josh Yang is the founder of Glyphic Biotechnologies. Glyphic Biotechnologies has raised $9M in total funding. Latest round: Seed. Based in United States.
Josh Yang is the Co-Founder and CEO of Glyphic Biotechnologies, a seed-stage biotech startup. He previously co-founded Nephrosant, a Series A diagnostics startup, which raised over $22 million in total funding. Yang holds a bioengineering double major from the University of California, San Diego.
Full founder directory · Investor directory · Company funding database · Fundraising library